Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 2, 2012, Pages 399-406

  Trifilieff, Alexandre ^a   Fozard, John R ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID; FINGOLIMOD; SPASMOGEN; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

AIRWAY HYPERREACTIVITY; AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CAUSAL ATTRIBUTION; DISEASE DURATION; HEART RATE; HYPOTENSION; IN VITRO STUDY; LUNG FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RESPIRATORY TRACT DISEASE; SMOOTH MUSCLE; TRACHEA;

ALBUTEROL; ANIMALS; ASTHMA; BETA-ALANINE; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTION; LUNG; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; PROPYLENE GLYCOLS; RATS; RATS, INBRED BN; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; TACHYPHYLAXIS; THIOPHENES; TRACHEA;

EID: 84864119788     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.191585     Document Type: Article

References (27)

1. Alexander SP, Mathie A, and Peters JA (2011) Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164:S1-S324.
2. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, Kane SA, Peters SP, Penn RB, Spiegel S, et al. (2001) Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 15:1212-1214.
3. Billich A, Bornancin F, Deváy P, Mechtcheriakova D, Urtz N, and Baumruker T (2003) Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 278:47408-47415. (Pubitemid 37523181)
4. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277:21453-21457. (Pubitemid 34952287)
5. Brusasco V, Crimi E, and Pellegrino R (1998) Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 53:992-998. (Pubitemid 28494343)
6. Chiba Y, Suzuki K, Uechi M, Kurihara E, Goto K, Sakai H, and Misawa M (2010a) Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma. Pharmacol Res 62:357-363.
7. Chiba Y, Takeuchi H, Sakai H, and Misawa M (2010b) SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. J Pharmacol Sci 114:304-310.
8. Ellis KM, Cannet C, Mazzoni L, and Fozard JR (2004) Airway hyperresponsiveness to bradykinin induced by allergen challenge in actively sensitised Brown Norway rats. Naunyn Schmiedebergs Arch Pharmacol 369:166-178. (Pubitemid 38270772)
9. Haberberger RV, Tabeling C, Runciman S, Gutbier B, König P, Andratsch M, Schütte H, Suttorp N, Gibbins I, and Witzenrath M (2009) Role of sphingosine kinase 1 in allergen-induced pulmonary vascular remodeling and hyperresponsiveness. J Allergy Clin Immunol 124:933-941.e1-9.
10. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G, Brown JH, and Chun J (2001) Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LPB3/EDG-3. J Biol Chem 276:33697-33704.
11. Jongsma M, Hendriks-Balk MC, Michel MC, Peters SL, and Alewijnse AE (2006) BML-241 fails to display selective antagonism at the sphingosine-1- phosphate receptor, S1P3. Br J Pharmacol 149:277-282. (Pubitemid 44453428)
12. Kume H, Takeda N, Oguma T, Ito S, Kondo M, Ito Y, and Shimokata K (2007) Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation. J Pharmacol Exp Ther 320:766-773. (Pubitemid 46147958)
13. Lai WQ, Goh HH, Bao Z, Wong WS, Melendez AJ, and Leung BP (2008) The role of sphingosine kinase in a murine model of allergic asthma. J Immunol 180:4323-4329.
14. Lundgren R, Söderberg M, Hörstedt P, and Stenling R (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1:883-889. (Pubitemid 19015298)
15. Maddox L and Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53:477-498. (Pubitemid 34177892)
16. Meno-Tetang GM, Li H, Mis S, Pyszczynski N, Heining P, Lowe P, and Jusko WJ (2006) Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2- (-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab Dispos 34:1480-1487. (Pubitemid 44285388)
17. Nishiuma T, Nishimura Y, Okada T, Kuramoto E, Kotani Y, Jahangeer S, and Nakamura S (2008) Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol 294:L1085-L1093.
18. Nixon GF (2009) Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 158:982-993.
19. Pan S, Mi Y, Pally C, Beerli C, Chen A, Guerini D, Hinterding K, Nuesslein-Hildesheim B, Tuntland T, Lefebvre S, et al. (2006) A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol 13:1227-1234. (Pubitemid 44762192)
20. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, et al. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316:295-298. (Pubitemid 46633109)
21. Rosenfeldt HM, Amrani Y, Watterson KR, Murthy KS, Panettieri RA Jr, and Spiegel S (2003) Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J 17:1789-1799. (Pubitemid 37214773)
22. Roviezzo F, D'Agostino B, Brancaleone V, De Gruttola L, Bucci M, De Dominicis G, Orlotti D, D'Aiuto E, De Palma R, Rossi F, et al. (2010) Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 42:572-577.
23. Roviezzo F, Di Lorenzo A, Bucci M, Brancaleone V, Vellecco V, De Nardo M, Orlotti D, De Palma R, Rossi F, D'Agostino B, et al. (2007) Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am J Respir Cell Mol Biol 36:757-762. (Pubitemid 46871431)
24. Ryan JJ and Spiegel S (2008) The role of sphingosine-1-phosphate and its receptors in asthma. Drug News Perspect 21:89-96. (Pubitemid 351628233)
25. Schuchardt M, Tölle M, Prüfer J, and van der Giet M (2011) Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol 163:1140-1162.
26. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, and Cyster JG (2005) Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739. (Pubitemid 41285945)
27. Zhou H and Murthy KS (2004) Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. Am J Physiol Cell Physiol 286:C1130-C1138. (Pubitemid 38506928)